Based on the Breslow-Day-Tarone test for heterogeneity, there was no indication of heterogeneity of the treatment eff ect for complete response across the studies (p>0·25 for all phases).
Based on the Breslow-Day-Tarone test for heterogeneity,there was no indication of heterogeneity of the treatmenteff ect for complete response across the studies (p>0·25for all phases).